BOARD OF DIRECTORS
President, Owner, and Operator
Sarah is the President, owner and operator of Kymanox. She funded Kymanox during its start-up and first year of operation and has led the following areas at Kymanox: Business Operations, Sales and Marketing, Client Services, and Human Resources. Prior to Kymanox, Sarah held positions of increasing responsibility for market development at J. P. Morgan Chase , Oakwood Corporate Housing, Texas Guaranteed (TG), Keller Graduate School of Management, Northwestern University, and North Carolina State University. Sarah graduated from Saint Mary’s College with a Bachelor’s of Arts degree. She is a member of Project Management Institute (PMI), Women in BIO, and Parenteral Drug Association (PDA).
CEO and Secretary
Stephen is the CEO, Secretary and founder of Kymanox. He has over 20 years of cGMP biopharma manufacturing experience as a process engineer, project manager, and regulatory advisor. Before starting Kymanox, Stephen held various leadership roles supporting successful scale-up, start-up and commercialization initiatives at M+W Group, Abbott Laboratories, Covance Biotechnology Services, Diosynth Biotechnology and Human Genome Sciences. Stephen graduated with high honors with a degree in Chemical Engineering from the University of Notre Dame. He has also studied at the graduate level at Purdue University. Stephen speaks regularly as an industry expert on technology transfer, project management, risk management, and validation.